Myocarditis Treatment Trial

• Status: Completed
• Trial end date: 1994-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine whether immunosuppressive treatment improved cardiac function in patients with biopsy-proven myocarditis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Utah
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Cyclosporine; Cyclosporins; Prednisone

Criteria

Men and women, 18 years of age or older, with left ventricular failure and biopsy-documented myocarditis.